Claris Biotherapeutics, Inc. research brief

CIK 1809726 Copy CIK

Generated Nov. 13, 2026, 6:29 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: HALF MOON BAY California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Aug. 12, 2026 · D/A · 0001809726-26-000004 · Source evidence

  Reported offering amount: 121477910 USD. Reported amount sold: 55737646 USD.

• Aug. 7, 2026 · D · 0001809726-26-000003 · Source evidence

  Reported offering amount: 121477910 USD. Reported amount sold: 55737646 USD.

• Sept. 22, 2025 · D · 0001809726-25-000004 · Source evidence

  Reported offering amount: 2300000 USD. Reported amount sold: 2300000 USD.

• March 7, 2025 · D · 0001809726-25-000001 · Source evidence

  Reported offering amount: 3300000 USD. Reported amount sold: 3299999 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Claris Biotherapeutics, Inc. research brief,” CIK 1809726, retrieved Nov. 13, 2026, 6:29 p.m.. Cite the specific accessions used. No amounts have been summed.